Reverse split vote looms for Autonomix Medical (AMIX)
Autonomix Medical (AMIX) will hold its annual meeting on October 29, 2026, to vote on a reverse stock split (ratio 1-for-2 to 1-for-25), expand its equity incentive plan, and elect directors. The company seeks approval for the board to implement the split within a year, which would reduce share count but maintain ownership percentages. AMIX had 1,828,505 shares outstanding as of September 8, 2026.
How this was made
The 30-second read
Why it matters
The vote outcome will determine whether the company can execute a reverse split, which may improve share price perception but also increase authorized shares for future issuance.
Market read
Primary corporate‑action filing with limited immediate market impact; relevance centers on the upcoming shareholder vote.
What to watch
Potential future equity compensation issuances from the expanded pool could dilute existing shareholders if not managed carefully.
Background
Autonomix Medical filed a proxy statement outlining a reverse‑split authority and an expanded equity incentive plan, to be voted on at its annual meeting.
Ticker impact
Company seeks shareholder approval for a reverse split authority and expanded equity incentive pool at its Oct 29, 2026 annual meeting.
Modest volatility around the vote; potential upside if split approved and market perceives it as a clean‑up.
The filing is a primary disclosure of a corporate action with limited material effect; investors may trade on the outcome but the event size is small.
Market effects
Minimal; reverse‑split votes are company‑specific and do not signal broader sector trends.
None; the company is a micro‑cap with limited regional influence.
None
Counterpoint
If the split is approved, the reduced share count could attract speculative buying, contrary to expectations of dilution.
Key entities
- CompanyAutonomix Medical, Inc.
Micro‑cap medical device firm seeking shareholder approval for a reverse split.
- AuditorForvis Mazars, LLP
Proposed independent auditor to be ratified by shareholders.
